Skip to Main Content
Diseases of the Cardiovascular System, Phase IIA

Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH)

What is the purpose of this trial?

This first-in-patient phase 2a pilot study will assess the safety and tolerability of MW01-6-189WH (hereafter called MW189) in patients with Intracerebral Hemorrhage (ICH).

  • Trial with
    Johns Hopkins University
  • Ages
    18 years and older
  • Gender

Contact Information

For more information about this study, including how to volunteer, contact Michael Kampp

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact, or call 877.978.8343 for more information.

  • Last Updated
  • Study HIC